David Rutherford

Title: David Rutherford - Innovator in Pharmaceutical Chemistry

Introduction

David Rutherford is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the treatment of iron deficiency anemia. With a total of four patents to his name, Rutherford's work has the potential to impact the medical community positively.

Latest Patents

Rutherford's latest patents include innovative compounds aimed at treating iron deficiency anemia. These compounds are described by a specific formula where R can be allyl, chlorine, bromine, phenyl, or phenyl substituted by one or more halogen or alkyl groups. The compounds also involve complex structures where one of X and Y is a group such as --CO--, --CHOH--, or --CH₂--, while the other is an exocyclic carbon-carbon bond linking the ferrocenyl or the R group to the --A-- group. The A group contains 5, 6, or 7 carbon atoms and can be either an ethylenically unsaturated cyclic hydrocarbon group or a saturated cyclic hydrocarbon group. Additionally, he has developed ferrocene compounds and pharmaceutical compositions for use in treatment.

Career Highlights

Throughout his career, David Rutherford has worked with reputable companies such as Fisons Ltd. and Frisons Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and the development of effective treatments.

Collaborations

Rutherford has collaborated with notable colleagues, including John L. Suschitzky and Peter Williams. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

David Rutherford is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of iron deficiency anemia. His innovative patents and collaborations reflect his commitment to improving healthcare solutions.